<code id='7C3714194F'></code><style id='7C3714194F'></style>
    • <acronym id='7C3714194F'></acronym>
      <center id='7C3714194F'><center id='7C3714194F'><tfoot id='7C3714194F'></tfoot></center><abbr id='7C3714194F'><dir id='7C3714194F'><tfoot id='7C3714194F'></tfoot><noframes id='7C3714194F'>

    • <optgroup id='7C3714194F'><strike id='7C3714194F'><sup id='7C3714194F'></sup></strike><code id='7C3714194F'></code></optgroup>
        1. <b id='7C3714194F'><label id='7C3714194F'><select id='7C3714194F'><dt id='7C3714194F'><span id='7C3714194F'></span></dt></select></label></b><u id='7C3714194F'></u>
          <i id='7C3714194F'><strike id='7C3714194F'><tt id='7C3714194F'><pre id='7C3714194F'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:9
          Micky Tripathi Office of the National Coordinator for Health Information Technology

          Micky Tripathi is equal parts excited — and deeply concerned — about the technological change sweeping through medicine.

          As adoption of generative AI races ahead,  his job as National Coordinator for Health Information Technology under President Joe Biden is to manage this change, and keep it safe and organized. But how do you organize a pell-mell rush? How do you keep chaos safe?

          advertisement

          “It’s definitely changed my life,” Tripathi said of his official remit, which also led to his appointment as co-chair of a task force on AI within the Department of Health and Human Services.  “We believe it’s really, really important that we be out ahead of this.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Readout Newsletter: Parkinson's study, Gilead, CG Oncology
          Readout Newsletter: Parkinson's study, Gilead, CG Oncology

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          How to protect patients from sexual assault

          AdobeHealthcareprovidershaveasacrosanctrelationshipwithpatients.Thatuniquepositionoftrustalsoputsthe